Super Force Jelly is a combination medication marketed in sachet form that contains two active ingredients: sildenafil and dapoxetine. Sildenafil belongs to the phosphodiesterase type 5 (PDE5) inhibitor class and is used to treat erectile dysfunction (ED). Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that is indicated for the treatment of premature ejaculation (PE). The product is supplied as a single-dose sachet delivering 100 mg of sildenafil and 60 mg of dapoxetine.
In Hong Kong the regulatory authority is the Department of Health (DH), which follows guidelines similar to those of the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). As of the time of writing, Super Force Jelly is not listed as an approved medication by the DH. The individual ingredients, sildenafil and dapoxetine, are each approved for their respective indications when used separately, but the combined formulation has not been formally evaluated for safety or efficacy by local regulatory bodies.
Sildenafil inhibits the enzyme phosphodiesterase type 5, which normally breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle of the penis. By blocking this enzyme, sildenafil prolongs the action of cGMP, leading to relaxed smooth muscle, increased blood flow to the corpora cavernosa, and the ability to achieve and maintain an erection when sexual stimulation is present.
Dapoxetine selectively blocks the reuptake of serotonin (5-HT) in the central nervous system, increasing serotonergic activity. Higher serotonin levels delay the ejaculatory reflex, thereby extending intravaginal latency time. Dapoxetine’s short half-life (about 1-2 hours) allows it to be taken on an “as-needed” basis close to sexual activity.
When both agents are taken together, sildenafil addresses the difficulty of achieving an erection, while dapoxetine helps control the timing of ejaculation. The combined effect is intended to improve overall sexual performance for men experiencing both ED and PE.
Both conditions are common and may coexist in the same individual. The separate ingredients have robust approval for these indications, but the combination product itself has not received regulatory approval in Hong Kong. Use of the combination should therefore be considered off-label and only undertaken under direct supervision of a qualified healthcare professional.
The combination of sildenafil and dapoxetine is not listed in official prescribing information. However, clinical practice sometimes involves co-prescribing these agents when a patient presents with both ED and PE. Peer-reviewed studies have demonstrated that treating each condition with its respective medication improves overall sexual satisfaction. No randomized controlled trial has evaluated the fixed-dose sachet formulation itself, so the safety and efficacy of taking both drugs together in a single sachet remain off-label.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment. Patients should discuss potential benefits and risks with their prescriber before using Super Force Jelly.
If any of the above conditions apply, patients should consult a healthcare provider before considering Super Force Jelly.
Patients should provide a complete medication list, including over-the-counter products and herbal supplements, to their prescriber.
Important: Dosing must be individualized. The information above provides a typical regimen but does not replace personalized medical advice.
Regular follow-up with a prescribing clinician ensures that therapy remains safe and effective.
Phosphodiesterase type 5 (PDE5) inhibitor: A drug class that blocks the PDE5 enzyme, enhancing blood flow to the penis and facilitating erection.
Selective serotonin reuptake inhibitor (SSRI): A class of antidepressants that increase serotonin levels in the brain; dapoxetine is a short-acting SSRI used for premature ejaculation.
Premature ejaculation (PE): A condition where ejaculation occurs with minimal sexual stimulation, often before the patient wishes, causing distress.
Intravaginal latency time (IVLT): The interval between vaginal penetration and ejaculation; a key metric in assessing treatment efficacy for PE.
Serotonin syndrome: A potentially life-threatening condition caused by excess serotonergic activity, presenting with agitation, hyperthermia, tremor, and autonomic instability.
Hypotension: Abnormally low blood pressure; can result from the vasodilatory effects of sildenafil, especially when combined with nitrates.
This article provides educational information about Super Force Jelly and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, the sachet can be carried in hand luggage, but it should be placed in its original packaging and declared if requested. Because the product contains prescription-only ingredients, you may be asked to show a valid prescription or a doctor’s note.
The formulation is designed to mask the bitter taste of the active ingredients, resulting in a mildly sweet flavor. Some users report a faint medicinal aftertaste, which can be reduced by mixing the jelly with a small amount of juice.
In Hong Kong the sachet typically features the brand name “Super Force Jelly” printed in English and Chinese, with a distinctive red and blue color scheme. The imprint code and batch number are printed on the side for traceability.
Both sildenafil and dapoxetine can be detected in urine drug screens. While they are not prohibited substances in most sports, some organizations may test for them. Employees subject to workplace drug testing should disclose any prescribed medications to the testing facility.
The concept emerged from clinical observations that many men with erectile dysfunction also experience premature ejaculation. Combining a PDE5 inhibitor with a short-acting SSRI aims to address both issues simultaneously, though formal clinical trials of the fixed-dose combination are limited.
A single sachet offers convenience by delivering both agents at once, potentially improving adherence. Pharmacologically, the effects are expected to be similar to taking each drug individually, but the combined formulation has not been formally studied for interaction or additive risk.
Storing at room temperature is sufficient. Refrigeration is not required and may cause the jelly to become overly thick, making it harder to dissolve.
As of now, the combination of sildenafil and dapoxetine in a single sachet is marketed only under the Super Force Jelly brand. Generic versions would require separate regulatory approval for the fixed-dose product.
A prolonged erection (priapism) lasting more than four hours is a medical emergency. Seek immediate care at the nearest emergency department; early treatment reduces the risk of permanent tissue damage.
